188 related articles for article (PubMed ID: 12538486)
1. Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function.
Hsieh JL; Wu CL; Lee CH; Shiau AL
Clin Cancer Res; 2003 Jan; 9(1):338-45. PubMed ID: 12538486
[TBL] [Abstract][Full Text] [Related]
2. The cytotoxic effect of E1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell lines.
Zhao J; Wang H; Wei L; Habib NA; Lu X; Wu M; Guo Y
Cancer Gene Ther; 2001 May; 8(5):333-41. PubMed ID: 11477453
[TBL] [Abstract][Full Text] [Related]
3. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
4. p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.
Vollmer CM; Ribas A; Butterfield LH; Dissette VB; Andrews KJ; Eilber FC; Montejo LD; Chen AY; Hu B; Glaspy JA; McBride WH; Economou JS
Cancer Res; 1999 Sep; 59(17):4369-74. PubMed ID: 10485485
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic drug, adriamycin, restores the function of p53 protein in hepatitis B virus X (HBx) protein-expressing liver cells.
Yun C; Lee JH; Park H; Jin YM; Park S; Park K; Cho H
Oncogene; 2000 Oct; 19(45):5163-72. PubMed ID: 11064453
[TBL] [Abstract][Full Text] [Related]
6. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.
Park EH; Koh SS; Srisuttee R; Cho IR; Min HJ; Jhun BH; Lee YS; Jang KL; Kim CH; Johnston RN; Chung YH
Cancer Gene Ther; 2009 May; 16(5):453-61. PubMed ID: 19096445
[TBL] [Abstract][Full Text] [Related]
7. COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.
Cheng AS; Yu J; Lai PB; Chan HL; Sung JJ
Biochem Biophys Res Commun; 2008 Sep; 374(2):175-80. PubMed ID: 18601905
[TBL] [Abstract][Full Text] [Related]
8. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
Lin J; Zhu MH; Qu JH; Li FM; Ni CR
Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
[TBL] [Abstract][Full Text] [Related]
9. Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus.
Habib NA; Mitry RR; Sarraf CE; Jiao LR; Havlík R; Nicholls J; Jensen SL
Cancer Gene Ther; 2002 May; 9(5):414-20. PubMed ID: 11961664
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
[TBL] [Abstract][Full Text] [Related]
11. [Anti-tumor effect of E1B55kDa-deleted adenovirus on human hepatocellular carcinoma cell lines].
Zhao J; Lü Y; Guo Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):366-8. PubMed ID: 11810762
[TBL] [Abstract][Full Text] [Related]
12. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells.
Wang W; Zhou D; Wei J; Wu Z; Cheng X; Sun Q; Xie H; Zhou L; Zheng S
Biochem Biophys Res Commun; 2012 May; 421(2):355-60. PubMed ID: 22510407
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma cells containing hepatitis B virus X protein have enhanced invasive potential conditionally.
Ou DP; Tao YM; Chang ZG; Tang FQ; Yang LY
Dig Liver Dis; 2006 Apr; 38(4):262-7. PubMed ID: 16461023
[TBL] [Abstract][Full Text] [Related]
15. [Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells].
Liu XH; Lin J; Cao XZ; Zheng JM; Chen Y; Zhu MH
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):825-30. PubMed ID: 15949399
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
Sirma H; Giannini C; Poussin K; Paterlini P; Kremsdorf D; Bréchot C
Oncogene; 1999 Aug; 18(34):4848-59. PubMed ID: 10490818
[TBL] [Abstract][Full Text] [Related]
17. Functional inactivation but not structural mutation of p53 causes liver cancer.
Ueda H; Ullrich SJ; Gangemi JD; Kappel CA; Ngo L; Feitelson MA; Jay G
Nat Genet; 1995 Jan; 9(1):41-7. PubMed ID: 7704023
[TBL] [Abstract][Full Text] [Related]
18. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.
Heise C; Lemmon M; Kirn D
Clin Cancer Res; 2000 Dec; 6(12):4908-14. PubMed ID: 11156251
[TBL] [Abstract][Full Text] [Related]
19. Detection of adenovirus and initiation of apoptosis in hepatocellular carcinoma cells after Ad-p53 treatment.
Mitry RR; Sarraf CE; Havlík R; Habib NA
Hepatology; 2000 Apr; 31(4):885-9. PubMed ID: 10733544
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
Oguey D; Dumenco LL; Pierce RH; Fausto N
Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
